14:13 IST
BSE
AcquisitionSudarshan Pharma Industries Ltd 543828
Sudarshan Pharma Industries Acquisition
Sudarshan Pharma stated its proposed 9.50% stake acquisition of Med Therapy Biotechnology Inc. remains under due diligence. Promoter acquisitions of 1.50% each are also pending.